Coherus Oncology CHRS
NASDAQ CHRS
$0.99 -0.08 (-7.48%)
At close: Oct 16, 2026 · 4:00 PM EDT

Coherus Oncology (CHRS) Total Liabilities (2013 - 2026)

Updated

Coherus Oncology's Total Liabilities came in at $130.35 million for Q2 2026, down 59.2% from $319.64 million a year earlier and down 30.4% from the prior quarter.

Analysis

Coherus Oncology (CHRS) Total Liabilities (2013 - 2026) Analysis & Trends

At the end of FY2025, Coherus Oncology's Total Liabilities was $197.33 million, down 66.0% from FY2024.

  • Total Liabilities carries a five-year compound annual growth rate of -18.8% (FY2020 to FY2025).
  • Going back by year, Total Liabilities was $580.52 million in FY2024 (-29.5%), $823.03 million in FY2023 (+33.1%), $618.27 million in FY2022 (+6.3%) and $581.61 million in FY2021 (+3.7%).
  • The Q2 2026 figure represents the lowest quarterly Total Liabilities since Q3 2018.
  • Year-over-year, Total Liabilities has declined for eight consecutive quarters, with an average decline of 44.8% over the last eight quarters.
  • The fastest year-over-year change in Total Liabilities over five years came in Q1 2024 (growth of 41.1%), and the weakest in Q1 2026 (a decline of 66.2%).
  • Business Quant data shows CHRS's Total Liabilities at $187.4 million (Q1 2026), $197.33 million (Q4 2025) and $428.75 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Liabilities (Qtr)
1 Eli Lilly 1,122.91 Bn 1,091.50 Bn 19.71 Bn 108.40 Bn
2 Johnson & Johnson 615.09 Bn 533.62 Bn 17.26 Bn 116.09 Bn
3 AbbVie 504.75 Bn 477.86 Bn 12.70 Bn 141.05 Bn
4 Merck 360.18 Bn 314.55 Bn 12.21 Bn 87.82 Bn
5 Novartis Ag 292.05 Bn 256.04 Bn 11.24 Bn 80.09 Bn
6 Astrazeneca 256.09 Bn 229.78 Bn 12.86 Bn 65.46 Bn
7 Amgen 233.63 Bn 189.02 Bn 7.24 Bn 83.95 Bn
8 Gilead Sciences 194.49 Bn 168.69 Bn 6.22 Bn 37.53 Bn
9 Pfizer 168.35 Bn 114.99 Bn 10.94 Bn 115.64 Bn
10 Coherus Oncology 155.59 Mn -480.55 Mn 10.07 Mn 130.35 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 130.35 Mn
Mar 31, 2026 187.40 Mn
Dec 31, 2025 197.33 Mn
Sep 30, 2025 428.75 Mn
Jun 30, 2025 319.64 Mn
Mar 31, 2025 554.54 Mn
Dec 31, 2024 580.52 Mn
Sep 30, 2024 592.97 Mn
Jun 30, 2024 758.96 Mn
Mar 31, 2024 845.39 Mn
Dec 31, 2023 823.03 Mn
Sep 30, 2023 717.38 Mn
Jun 30, 2023 644.36 Mn
Mar 31, 2023 598.93 Mn
Dec 31, 2022 618.27 Mn
Sep 30, 2022 648.04 Mn
Jun 30, 2022 568.63 Mn
Mar 31, 2022 580.82 Mn
Dec 31, 2021 581.61 Mn
Sep 30, 2021 610.97 Mn
API Access

Coherus Oncology Total Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-liabilities&ticker=CHRS&period=max&api_key=YOUR_API_KEY